Walk for Hospice Care – Star Shine Night Walk is back in Cambridge!
A celebratory sunset walk on Saturday 22 June for adult hospice care.
The future of cardiovascular treatments across the world
In this episode of Transforming Healthcare, host Jay Evans and Dr Bipin Patel are joined by Ami Bhatt, MD.
eg technology’s Co-Founder, Andrew Ede, retires
Andrew Ede, eg technology's Co-Founder, retires after 22 years.
More about supply chain and 3rd party risk management
Did you know that only 13% of businesses review the risks posed by their immediate suppliers? In recent years there has been a significant increase in the number of cyber attacks as a result of vulnerabilities within the supply chain.
Start up grant aims to support medical device industry innovation
Springboard Pro proudly announces the launch of its 2024 Start-up Grant.
Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Dublin, Ireland : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual prop
What is White Teaming in Cyber Security?
White teaming is a simulated cyber-attack exercise designed to test and improve an organisation’s security posture and incident response capabilities.
Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration
Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.
Helena Laughton joins Salus Wellness Clinics
The team are happy to announce that Helena Laughton has joined Salus Wellness.
Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines
Castleford and London: Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.
Ubiquigent and Debiopharm Enter Agreement to Support USP1 Inhibitor Programme for Debio 0432
Project will be a demonstration of how Ubiquigent’s DUB-centric platform can support the development of DUB inhibitors all the way from discovery through to clinical development.
Navigating long COVID: Insight into breathing pattern disorder and the journey to recovery
Co-authored by Dr. Andrew Potter, Whaddon Medical Centre.
Cambridge Science Centre are looking for a Young Trustee
Could you help to create a future where all children enjoy, explore and shape the world through STEM?
Chinese consumer tech companies’ visit to Cambridge - innovation and exchange of ideas
VR, AI, IoT, industrial innovation, just some of the topics we covered in one day – what a productive visit for these Chinese consumer tech companies in Cambridge!
Latest research shows sustained employment growth across the region’s diverse economy
Cambridge: The latest annual monitor of the Cambridge city region’s economy from Cambridge Ahead shows that job creation is positive across all sectors in the region, with major employment growth being driven by knowledge-intensive sectors.
Healthcare programme receives national award
NHS Clinical Entrepreneur Programme, delivered by ARU, is recognised by HSJ.
Somerset’s NHS pioneers clinical use of AI software to transform prostate cancer diagnosis
A ground breaking way of supporting doctors to diagnose prostate cancer using the latest artificial intelligence (AI) technology has launched in Somerset.
New research partnership celebrates successful completion of first study
CPFT’s Windsor Research Unit has been praised for successfully delivering one of the first studies in the UK to test new wearable devices to assess brain health and memory, in a new research partnership.
Over 20,000 surgical cases completed using Versius
CMR Surgical – the global surgical robotics business – announces that over 20,000 Versius surgical cases have now been completed as the Company works with hospitals and surgeons around the world to bring minimal access surgery to everyone who needs it.
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.